As told RITs "Yugra" in the press service of Chamber of Commerce and Industry of Khanty-Mansi Autonomous Okrug-Yugra, meeting of Committee of business cooperation of the countries of BRICS in which representatives of pharmaceutical holding JSC Edvansd Trading (India), and also district authorities took part here took place.
of Alfiya Pavkin, the chairman of Committee of business cooperation of the countries of BRICS, emphasized that "the main objective of Chamber of Commerce and Industry is involvement of investors and partners of the countries of BRICS".
the Edvansd Trading Company at present is the investor of the Belgorod region where construction of pharmaceutical plant is conducted and the first stage is handed already over. They conduct active work on expansion of the activity in the pharmaceutical market of Russia and today are ready to make presentation of the production presented in the territory of our country".
Among priority ways of development of cooperation Vladislav Nigmatullin, the first deputy director of the department of health care of Khanty-Mansi Autonomous Okrug-Yugra, called exchange of information according to the analysis of the market of medicines with representatives of pharmaceutical holding of India. Anshuman Sharma, the commercial director of pharmaceutical holding JSC Edvansd Trading confirmed with
intentions of the company to develop in the market of Russia within implementation of programs of import substitution and attraction of foreign investments into the country industry. He reported that along with antitubercular preparations, production of the tableted and encapsulated medicines from various pharmacological groups is planned. we Will note
that the JSC Edvansd Trading company is in the pharmaceutical market of the Russian Federation since 2003 and is the participant of the federal programs "Strategy of Development of Pharmaceutical Industry of the Russian Federation for the Period till 2020" and "Comprehensive long-term program of cooperation in the field of science, equipment and innovations till 2020".